https://www.selleckchem.com/pr....oducts/6-diazo-5-oxo
Group 5 patients had a longer hospital stay (median 37days, p=0.0001), a more aggressive disease (6 out of 27, 22%, died), more often need admission to ICU (n=25, 92.6%, p0.0001), and show one or more peak values, sometime preceded by severe hypoxia. In SARS-CoV-2 patients, hs-cTnI serial monitoring may provide additional data to stratify risk, establish prognosis and gaining epidemiological insight on cardiac involvement in this pandemic disease. In SARS-CoV-2 patients, hs-cTnI serial monitoring may provide addit
Like
Comment
Share
